Saint-Remy Biomedicals SRL
Saint-Remy Biomedicals reported total assets of 55,473 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Mar 2026).
The score of Saint-Remy Biomedicals shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +159 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Saint-Remy Biomedicals's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 30 Mar 2026
- Year ended 30 Sep 2024filed on 07 Apr 2025
- Year ended 30 Sep 2023filed on 17 Apr 2024
- Year ended 30 Sep 2022filed on 24 Apr 2023
- Year ended 30 Sep 2021filed on 22 Apr 2022
Saint-Remy Biomedicals's financial analysis
- Solvency-80.9%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Saint-Remy Biomedicals
Saint-Remy Biomedicals's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0810.927.522
- VAT number
- BE0810927522
- Peppol
- Registered · 0208:0810927522 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Mar 2009
- Registered office
- 1390 Grez-Doiceau
- Latest accounts
- 2025 · filed on 30 Mar 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Saint-Remy Biomedicals (SRL) has been based in Grez-Doiceau since 2009, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 9,472 € and equity of −44,890 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Saint-Remy Biomedicals
Companies in the same business, of comparable size and area, outside its group.
- Zagre Diagnostic imaging services and medical laboratory activities Seraing · balance sheet 49,598 €
- CTTec Research and experimental development on natural sciences and engineering Menen · balance sheet 259,750 €
- JN-RD Research and experimental development on natural sciences and engineering Oreye · balance sheet 67,834 €
- Impact Omics Diagnostic imaging services and medical laboratory activities Tongeren-Borgloon · balance sheet 102,349 €
- SciLife Consulting Research and experimental development on natural sciences and engineering Kortenberg · balance sheet 198,474 €
- Polyphemus Research and experimental development on natural sciences and engineering Watermael-Boitsfort · balance sheet 34,603 €
- Yagh Penn Consulting Research and experimental development on natural sciences and engineering Bertem · balance sheet 34,428 €
- Ferrons Research and experimental development on natural sciences and engineering Ternat · balance sheet 231,903 €
Frequently asked questions about Saint-Remy Biomedicals
What is the revenue of Saint-Remy Biomedicals?
Saint-Remy Biomedicals files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Saint-Remy Biomedicals?
In Belgium, the VAT number is the company number prefixed with BE: BE0810927522 for Saint-Remy Biomedicals, if the company is VAT-registered. Its company number (CBE) is 0810.927.522.
Where is the registered office of Saint-Remy Biomedicals?
According to the CBE register, the registered office of Saint-Remy Biomedicals is in 1390 Grez-Doiceau.
What is the equity of Saint-Remy Biomedicals?
At the close of the 2025 financial year, the equity of Saint-Remy Biomedicals amounts to -44,890 €, a solvency of -80.9% of total assets.
Who manages Saint-Remy Biomedicals?
The register lists 1 active mandates at Saint-Remy Biomedicals. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Saint-Remy Biomedicals
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →